Remote Symptom Monitoring on Patient-Reported Outcomes With Nudge Strategies Among Patients With Tumor in China

Launched by WEI XIAOPING · Apr 14, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how a digital tool can help patients with liver cancer, also known as hepatocellular carcinoma (HCC), manage their symptoms better. The researchers want to find out if having patients regularly report their symptoms online can help them understand their health, manage their care, and improve their overall well-being. They will compare two groups of participants: one group will use the digital tool to share their symptoms weekly and receive helpful advice, while the other group will not use this tool. The goal is to see if this approach can lead to better symptom control and a higher quality of life for cancer patients.

To participate in the trial, you need to be between 18 and 75 years old and have been diagnosed with advanced liver cancer. You should also be receiving or have completed specific treatments related to your cancer. Participants will be able to share their symptoms online each week, and they can choose to leave the study at any time if they want. It’s important to note that individuals with cognitive difficulties or who cannot understand the study may not be eligible. This trial is not yet recruiting participants, but it offers an exciting opportunity to explore how technology might improve care for patients facing serious health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The patients are aged between 18 and 75 years old;
• • 2. The patients have been diagnosed with locally advanced or metastatic liver cancer through pathological or imaging examinations;
• • 3. The patients are currently receiving or have completed PD-1 monotherapy or PD-1 combination therapy;
• • 4. The patients can participate in this study as per the requirements of the research protocol;
• • 5. The patients voluntarily sign the informed consent form.
• Exclusion Criteria:
• • 1. The patients have cognitive impairment or are unable to clearly identify their own symptoms and feelings;
• • 2. The patients are illiterate or unable to understand the research content for other reasons;
• • 3. The patients are currently participating in other clinical trials that may affect this study.